Our in vivo experiments reveal that administration of recombinant Klotho attenuates CKD-induced aortic valve lesions, resulting in reduced aortic valve thickening and calcification in old mice subjected to CKD protocol. The gene discussed is KL; the disease is chronic kidney disease.